Latest Endometrial intraepithelial neoplasia Stories
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer, according to scientists from the Icahn School of Medicine at Mount
Adding genomics-based testing to standard patient evaluation process could drastically alter the recommended treatment program for women with endometrial cancer, as well as the classification of that form of cancerous tumor.
Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.
We dream of a world where we can eat whatever we like and not worry about the consequences, like weight gain and health issues, and now we might be a step closer.
This result, obtained after five years' research, is published in leading journal Cell Metabolism.
In a perfect world, we could eat to our heart's content without sacrificing our health and good looks, and now it appears that maybe we can.
Researchers at Queen’s University have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer.
ASCO Abstract #10504. Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin.